ESMO ESMO 2023: Highlights on sotorasib plus panitumumab in KRAS G12C-mutated mCRC: The CodeBreak 300 study By ONA Editor October 23, 2023 No Comments Share Tweet Pinterest LinkedIn Tumblr Email + Share. Twitter Facebook Pinterest LinkedIn Tumblr Email
For colon cancer that no longer responds to treatment, a new drug combination offers hope May 2, 2025 0
Breakthrough combination therapy tackles drug resistance in lung cancer with common KRAS mutation March 27, 2025 0